Le Lézard
Classified in: Health, Science and technology
Subjects: AWD, PLW

Immunolight, LLC Receives 200th Worldwide Patent


DURHAM, N.C., Sept. 14, 2021 /PRNewswire/ -- Immunolight, LLC, a clinical stage biopharmaceutical firm leading the way in advancing technologies to transform cancer treatment, announced today it has been granted its 200th worldwide and 75th US patent in a wide-ranging patent portfolio.  The Immunolight patent estate continues to expand, with patents covering both the medical and non-medical commercial end-uses of the breakthrough Immunolight energy conversion technology.  An additional 117 worldwide patent applications are pending. 

Immunolight, LLC

"Extensively patenting our innovative technology has been a high priority to ensure market exclusivity in key high value markets," says Immunolight founder and CEO Rick Bourke.

The current portfolio contains over 70 issued or allowed worldwide patents having claims specifically related to medical treatments.  A predominant focus of these medical patents is the new paradigm for the treatment of cancer and other cell proliferation disorders made possible by the unique Immunolight energy conversion technology.  Immunolight has recently received FDA clearance to enter phase 1 study in patients with breast, melanoma, sarcoma and head and neck cancers.

The non-medical commercial application cases have a broad scope of various technologies, with a predominant focus on the curing of adhesives and polymers using Immunolight's energy conversion technology, thus providing the ability to cure at room temperature without requiring line-of-sight between an activation energy source and the site being cured.  Also covered are many other commercial end-uses, including, but not limited to, solar cells, the generation or enhancement of color, and electronics/semiconductors.

"With many exciting discoveries on Immunolight's horizon, it is expected that the portfolio will continue to grow for years to come, ultimately providing a rich multi-layered territory of exclusive rights in both medical and commercial applications of the innovative Immunolight energy conversion technology," says Immunolight President Harold Walder.

About Immunolight, LLC

Illumination | Innovation | Transformation

Founded in 2007, Immunolight, LLC's mission is to innovate advancements in energy conversion technologies that create value in medicine, commercial industries and the life sciences.  Immunolight has developed a breakthrough platform technology that leverages the latest advances in energy conversion. The technology is centered on energy conversion from one part of the electromagnetic spectrum to another and the paradigm-shifting applications in medicine, and commercial fields including adhesives, solar energy, electronics, commercial and industrial paints, and cosmetics. 

For more information please contact:

Harold Walder
President
Immunolight, LLC
[email protected]

Logo - https://mma.prnewswire.com/media/1624805/Immunolight_LLC_Logo.jpg


These press releases may also interest you

at 15:17
Schools and colleges across the country rely on Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) evaluations to assess and manage student-athlete concussions on the sidelines. However, this FDA-cleared tool is not recommended for...

at 15:05
MAIA Biotechnology, Inc., ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that independent directors Cristian Luput and Ramiro Guerrero, J.D, LL.M. made individual...

at 15:05
University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD, announced today that Martine Rothblatt PhD, JD, MBA, Chairperson and CEO of United Therapeutics, and inventor of SiriusXM Satellite Radio, will deliver the keynote address...

at 15:00
Beghou Consulting announced Thursday several additions to its executive team to support the company's technology innovation, product development and growth initiatives. Dan Cardinal, a Partner at Beghou, will become Chief Technology Officer. The...

at 15:00
Urban Wellness Group, a pioneering wellness provider, is proud to announce its official launch of new anti-aging and sleep enhancement treatments to southeast Portland. Dr. Jason Zabell and Dr. Andy Swanson set themselves apart by pairing over 30...

at 14:55
Peninsula Canada, a global leading HR and health & safety firm, committed to making a positive impact in the community, is proud to announce a partnership with SickKids Foundation, a leading charity dedicated to supporting The Hospital for Sick...



News published on and distributed by: